Most marketed drugs are not optimized for their full potential; more than 60% have problems with solubility, permeability or both.
More than 60% of the marketed drugs have problems with solubility, permeability, or both.
These drugs are not utilized to their full potential.
Sarfez Pharmaceuticals is developing innovative technologies that improve under performing medications.
The hallmark of our strategy are modest investments, lower risks and short development duration.
Sarfez Pharmaceuticals is committed to providing improved drugs at affordable prices.